GENB compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

GENBGenerate Biomedicines, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

GENBGenerate Biomedicines, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GENB 4

AMGNAmgencustomer

NVSNovartis Pharmacustomer

—The University of Texas MD Anderson Cancer Centerunlistedsupplier

—Roswell Park Comprehensive Cancer Centerunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

GENBGenerate Biomedicines, Inc.

13.00▲+3.42%

Mkt cap$1.6BRevenue$6MQ2 FY26Revenue—

LLYELI Lilly & Co

1,368.40▲+0.27%

Regular sessionNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 6 '26

GENBGenerate Biomedicines, Inc.

LLYELI Lilly & Co

13.00▲+3.42%

Price

1,368.40▲+0.27%

$1.6B

Mkt cap

$1.2T

Q2 FY26$6M

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

GENB13.00▲+3.42%vsLLY1,368.40▲+0.27%Regular sessionNov 6 '26